Evidence map›Paper›PMID 29268715›Full record

ArticleBMC bioinformatics2017

Super-delta: a new differential gene expression analysis procedure with robust data normalization.

Yuhang Liu, Jinfeng Zhang, Xing Qiu

Abstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuhang LiuDepartment of Statistics, Florida State University, Tallahassee, 32306, FL, USA.
Jinfeng ZhangDepartment of Statistics, Florida State University, Tallahassee, 32306, FL, USA. jinfeng@stat.fsu.edu.
Xing QiuDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, 14624, NY, USA. Xing_Qiu@URMC.Rochester.edu.

Funding

Virology/Immunology CoreP30AI078498 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2018
$14.6M
The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
Collaborative Research: Mathematical Framework for Biomolecules: From Protein to RNA to ChromosomesR01GM126558 · NIGMS · FLORIDA STATE UNIVERSITY · PI ZHANG, JINFENG · 2017 to 2021
$1.5M
NCATS NIH HHS UL1 TR000042NIAID NIH HHS HHSN272201200005CNIAID NIH HHS P30 AI078498NIGMS NIH HHS R01 GM126558NIGMS NIH HHS R01GM126558.
6 · The paper itself

Abstract

backgroundNormalization is an important data preparation step in gene expression analyses, designed to remove various systematic noise. Sample variance is greatly reduced after normalization, hence the power of subsequent statistical analyses is likely to increase. On the other hand, variance reduction is made possible by borrowing information across all genes, including differentially expressed genes (DEGs) and outliers, which will inevitably introduce some bias. This bias typically inflates type I error; and can reduce statistical power in certain situations. In this study we propose a new differential expression analysis pipeline, dubbed as super-delta, that consists of a multivariate extension of the global normalization and a modified t-test. A robust procedure is designed to minimize the bias introduced by DEGs in the normalization step. The modified t-test is derived based on asymptotic theory for hypothesis testing that suitably pairs with the proposed robust normalization.

resultsWe first compared super-delta with four commonly used normalization methods: global, median-IQR, quantile, and cyclic loess normalization in simulation studies. Super-delta was shown to have better statistical power with tighter control of type I error rate than its competitors. In many cases, the performance of super-delta is close to that of an oracle test in which datasets without technical noise were used. We then applied all methods to a collection of gene expression datasets on breast cancer patients who received neoadjuvant chemotherapy. While there is a substantial overlap of the DEGs identified by all of them, super-delta were able to identify comparatively more DEGs than its competitors. Downstream gene set enrichment analysis confirmed that all these methods selected largely consistent pathways. Detailed investigations on the relatively small differences showed that pathways identified by super-delta have better connections to breast cancer than other methods.

conclusionsAs a new pipeline, super-delta provides new insights to the area of differential gene expression analysis. Solid theoretical foundation supports its asymptotic unbiasedness and technical noise-free properties. Implementation on real and simulated datasets demonstrates its decent performance compared with state-of-art procedures. It also has the potential of expansion to be incorporated with other data type and/or more general between-group comparison problems.

Indexed as

AlgorithmsDatabases, GeneticGene Expression Regulation, NeoplasticBreast NeoplasmsComputer SimulationFemaleGene Expression ProfilingGenes, NeoplasmHumansMolecular Sequence AnnotationReference StandardsDifferential expression analysisGene expressionModified t-testRobust normalizationSuper-delta

Identifiers

PMID29268715
PMCPMC5740711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.